HAP Trading’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,545
Closed -$8.77M 808
2024
Q4
$8.14M Buy
+10,545
New +$8.73M 0.71% 24
2022
Q4
Sell
-13,981
Closed -$4.96M 1719
2022
Q3
$4.52M Buy
+13,981
New +$4.43M 0.3% 82
2020
Q3
Sell
-43,191
Closed -$6.68M 1742
2020
Q2
$7.09M Buy
+43,191
New +$6.63M 0.39% 46
2019
Q4
Sell
-13,339
Closed -$1.49M 1369
2019
Q3
$1.49M Buy
+13,339
New +$1.49M 0.12% 147
2019
Q1
Sell
-31,517
Closed -$3.83M 1251
2018
Q4
$3.65M Buy
+31,517
New +$3.52M 0.23% 87
2017
Q1
Sell
-76,532
Closed -$6.13M 1182
2016
Q4
$5.63M Sell
76,532
-138,293
-64% -$10.3M 0.28% 73
2016
Q3
$17.2M Buy
+214,825
New +$17.2M 0.61% 17
2016
Q2
Sell
-10,055
Closed -$757K 988
2016
Q1
$724K Buy
+10,055
New +$761K 0.05% 255
2015
Q1
Sell
-25,644
Closed -$1.83M 1100
2014
Q4
$1.77M Buy
+25,644
New +$1.73M 0.07% 212
2014
Q1
Sell
-11,999
Closed -$612K 1226
2013
Q4
$612K Sell
11,999
-181,773
-94% -$9.1M 0.02% 539
2013
Q3
$9.75M Buy
193,772
+156,066
+414% +$8.17M 0.31% 68
2013
Q2
$1.85M Buy
+37,706
New +$2.05M 0.06% 252

Other funds holding LLY

HAP Trading's LLY Position: Q1 2025 in Review

HAP Trading sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 10,545 shares — an estimated $8.77M sold.

HAP Trading first reported a position in LLY in Q2 2013 and held it in 12 quarters. The position peaked at $17.2M in Q3 2016. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • HAP Trading reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • HAP Trading sold 10,545 Eli Lilly shares in Q1 2025, an estimated $8.77M.
  • HAP Trading first reported a position in Eli Lilly in Q2 2013 and held it in 12 quarters.
  • HAP Trading's Eli Lilly position peaked at $17.2M in Q3 2016.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on HAP Trading's 13F filing for Q1 2025, filed 14 May 2025.